Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 262 posts found.

Bayer UK Levitra tweet

Digital Pharma: Bayer tweets breach ABPI Code of Practice

July 5, 2011
Medical Communications Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter, medical communications news, social media

Bayer’s use of Twitter has caused the first social media breach of the ABPI Code of Practice. Code regulator the …

News

Xarelto receives FDA approval

July 4, 2011
Sales and Marketing Bayer, Eliquis, Johnson & Johnson, Pradaxa, Xarelto, anticoagulant

Bayer and Johnson & Johnson’s oral blood thinner Xarelto has been approved in the US for the prevention of deep …

News

Bayer submits Lucentis rival for European approval

June 7, 2011
Sales and Marketing Bayer, Lucentis, Regeneron, VEGF Trap-Eye

Bayer Healthcare has submitted its new eye drug to European regulators for approval to treat age-related macular degeneration (wet AMD). …

News

Bayer wields the axe at Emeryville plant

May 31, 2011
Manufacturing and Production Bayer, Emeryville, MS

Bayer Healthcare says it will cut 540 jobs at a production facility in Emeryville, California, next year after shifting production …

News

Bayer contraceptive advert breaches Code of Practice

May 27, 2011
Medical Communications ABPI Code of Practice, Bayer, Multaq, Sanofi, Yasmin

Bayer Healthcare has been singled out for “particular censure” by the PMCPA, the body which regulates the ABPI Code of …

News
Bayer

FDA fast-tracks Bayer’s GIST drug regorafenib

May 10, 2011
Sales and Marketing Bayer, GIST, regorafenib

The assessment of Bayer HealthCare’s investigational drug regorafenib is to be fast-tracked by US authorities for the treatment of stomach …

News
Bayer UK Twitter Levitra

Digital Pharma: Bayer UK’s Twitter slip-up

April 26, 2011
Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA, Twitter, medicial communications

There seems to be some confusion at Bayer UK over what communications can be sent over Twitter. The company is …

News

Bayer defends Yasmin against BMJ studies

April 26, 2011
Sales and Marketing Bayer, Yasmin, contraception

Bayer has rallied strongly behind its top-selling contraceptive brand Yasmin after two studies in the British Medical Journal questioned the …

News

Bayer drug enters phase III for diabetic macular oedema

April 11, 2011
Sales and Marketing Bayer, Lucentis, ophthalmology

Bayer and partner Regeneron have begun late stage trials for their VEGF Trap Eye candidate for diabetic macular oedema. The …

News

Bayer-helmed oncology biomarker project launched

March 14, 2011
Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …

News
Bayer's Marijn Dekkers

Bayer goes for pharma growth

March 1, 2011
Research and Development, Sales and Marketing 2010 pharma results, Bayer, Dr Jörg Reinhardt, Marijn Dekkers, Nexavar, VEGF Trap-Eye, Xarelto

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …

Feature

Bayer’s regorafenib gains orphan status for GIST

February 4, 2011
Research and Development, Sales and Marketing Bayer, FDA, GIST, gastrointestinal stromal tumours, orphan drug, regorafenib

Bayer’s investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumours (GIST) …

News

Bayer and Zydus Cadila sign India deal

February 4, 2011
Sales and Marketing Bayer, India, Indian pharmaceutical industry, Zydus Cadila

Bayer HealthCare and the Indian company Zydus Cadila have signed a deal to form a new joint venture. A new …

News
Blog footer

Digital Pharma: NHS thrombosis e-learning

January 14, 2011
Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism

The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …

News

Bayer submits new Xarelto indications for European approval

January 6, 2011
Sales and Marketing Bayer, DVT, Xarelto, atrial fibrillation, deep vein thrombosis, pulmonary embolism, rivaroxaban, stroke prevention

Bayer is seeking European regulatory approval for a batch of new indications for its oral anticoagulant Xarelto. The company is …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025